⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL9248047 | 1.00 | — | — | |
| Propane SCHEMBL23590 | 0.94 | — | — | |
| Propane SCHEMBL25366971 | 0.94 | — | — | |
| Propane SCHEMBL10466038 | 0.88 | — | — | |
| Propane SCHEMBL28102546 | 0.88 | — | — | |
| Propane SCHEMBL28551707 | 0.88 | — | — | |
| Propane SCHEMBL28102545 | 0.88 | KDM4E (0.40) | — | |
| Propane SCHEMBL28015864 | 0.82 | — | — | |
| Dimethylamine SCHEMBL292029 | 0.79 | — | — | |
| Propane SCHEMBL187937 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1748786-A4 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | VICURON PHARM INC (US) | 2009-07-15 | — | — | EP | disclosed |
| EP-1748786-A2 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | Vicuron Pharmaceuticals, Inc. (US) | 2007-02-07 | — | — | EP | disclosed |
| WO-2006078277-A2 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | VICURON PHARMACEUTICALS INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| EP-1565201-A1 | METHODS OF ADMINISTERING DALBAVANCIN FOR TREATMENT OF BACTERIAL INFECTIONS | Vicuron Pharmaceuticals, Inc. (US) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004045636-A1 | METHODS OF ADMINISTERING DALBAVANCIN FOR TREATMENT OF BACTERIAL INFECTIONS | VICURON PHARMACEUTICALS INC. (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004045637-A1 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | VICURON PHARMACEUTICALS INC. (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004046196-A2 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS WITH PROTEIN-DALBAVANCIN COMPLEXES | VICURON PHARMACEUTICALS INC. (US) | 2004-06-03 | — | — | WO | disclosed |